{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:44Z","timestamp":1772121704921,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.05.034","type":"journal-article","created":{"date-parts":[[2009,5,31]],"date-time":"2009-05-31T04:16:58Z","timestamp":1243743418000},"page":"4483-4489","source":"Crossref","is-referenced-by-count":49,"title":["Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX\u00ae1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study"],"prefix":"10.1016","volume":"27","author":[{"given":"A.","family":"Kaltenb\u00f6ck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dubischar-Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Paulke-Korinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"von Sonnenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Spruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Wiedermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.05.034_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidem Rev"},{"key":"10.1016\/j.vaccine.2009.05.034_bib2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0140-6736(90)91036-A","article-title":"Further experience with Japanese encephalitis vaccine","volume":"335","author":"Sanchez","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.05.034_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(91)92707-9","article-title":"Side-effects with Japanese encephalitis vaccine","volume":"337","author":"Anderson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.05.034_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","article-title":"Adverse reactions to Japanese encephalitis vaccine","volume":"338","author":"Ruff","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.05.034_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinids\/24.2.265","article-title":"Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine","volume":"24","author":"Berg","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.034_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(97)00020-0","article-title":"Allergic mucocutaneous reactions to Japanese encephalitis vaccine","volume":"15","author":"Plesner","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.034_bib7","first-page":"241","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"9602","key":"10.1016\/j.vaccine.2009.05.034_bib8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.05.034_bib9","unstructured":"Centers of Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization. Recommendations and Reports 2006; 55(RR07): 1\u201323. Available at: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5507a1.htm."},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.034_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2006.08.044","article-title":"Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.034_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","article-title":"A review of the long-term protection after hepatitis A and B vaccination","volume":"5","author":"van Damme Van Herck","year":"2007","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.034_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0035-9203(69)90031-5","article-title":"Assay of arbovirus neutralizing antibody by micro methods","volume":"63","author":"Sukhavachana","year":"1969","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"45","key":"10.1016\/j.vaccine.2009.05.034_bib13","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.034_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0006-341X.2000.00304.x","article-title":"Estimating risk difference in multicenter studies under baseline-risk heterogeneity","volume":"56","author":"B\u00f6hning","year":"2000","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.034_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jmv.1890440422","article-title":"Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity","volume":"44","author":"van Damme","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2009.05.034_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis\u2014within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.05.034_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","article-title":"Allergic reactions to Japanese encephalitis vaccine","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.034_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1708-8305.2007.00140.x","article-title":"A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?","volume":"14","author":"Caramello","year":"2007","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.034_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1708-8305.2007.00134.x","article-title":"Japanese encephalitis for a reference to international travelers","volume":"14","author":"Oya","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.05.034_bib20","unstructured":"World Health Organization: International travel and health 2008. Situation as on 01. January 2008. Geneva: World Health Organization; 2008."},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.034_bib21","first-page":"119","article-title":"Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age\u2014impact of risk factors","volume":"56","author":"Chl\u00edbek","year":"2007","journal-title":"Epidemiol Mikrobiol Imunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.05.034_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CDLI.7.1.111-113.2000","article-title":"Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines","volume":"7","author":"Atabani","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.034_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis A vaccine in HIV-positive patients","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepat"},{"issue":"18","key":"10.1016\/j.vaccine.2009.05.034_bib24","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/S0264-410X(98)00480-0","article-title":"Comparison of immunogenicity of two hepatitis A vaccines \u2013 VAQTA and HAVRIX \u2013 in young adults","volume":"17","author":"Ashur","year":"1999","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2009.05.034_bib25","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0264-410X(98)00352-1","article-title":"Comparative immunogenicity and tolerance of Vaqta and Havrix","volume":"17","author":"Braconier","year":"1999","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.05.034_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0264-410X(00)00301-7","article-title":"Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines","volume":"19","author":"Bryan","year":"2000","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2009.05.034_bib27","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.vaccine.2004.11.024","article-title":"Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine","volume":"23","author":"Bovier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.034_bib28","unstructured":"HAVRIX\u2122: product approval information. Summary for basis of approval. Available at: http:\/\/www.fda.gov\/cber\/sba\/havrixS.pdf (accessed 07 May 2008)."},{"issue":"3","key":"10.1016\/j.vaccine.2009.05.034_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0166-0934(93)90147-J","article-title":"Time course of hepatitis A antibody production after active, passive and active\/passive immunisation: the results are highly dependent on the antibody","volume":"43","author":"Berger","year":"1993","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2009.05.034_bib30","unstructured":"Jilg W, Mayer J, Pl\u00f6tz K, Baier, B, Hottentr\u00e4ger B. Vergleich zweier Anti-HAV-Teste zur Messung spezifischer Antik\u00f6rper nach Hepatitis-A-Impfung. In: Maass G, St\u00fcck B., editors. Abstract in: Virushepatitis A bis E Diagnose, Therapie, Prophylaxe; 1994."},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.034_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10096-002-0861-7","article-title":"Evaluation of three commercial assays for the detection of hepatitis a virus","volume":"22","author":"Wiedmann","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:53:25Z","timestamp":1589835205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09007142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":31,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09007142"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164307.626024","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}